5/14/2010

ConjuGon has obtained $1.9 million in equity financing as it attempts to secure a total of $4.75 million, according to a regulatory filing. The Wisconsin-based biotech firm is working on drug candidates for catheter-related urinary tract infections and antibiotic-resistant wound infections.

Related Summaries